Psyence Biomedical Ltd

NEW
NAS:PBM (Canada)  
$ 1.85 -0.19 (-9.31%) 11:08 PM EST
At Loss
Enterprise V:
$ 11.44M
Volume:
276.92K
Avg Vol (2M):
1.05M
Trade In:
Volume:
276.92K
At Loss
Avg Vol (2M):
1.05M

Business Description

Psyence Biomedical Ltd
NAICS : 541715 SIC : 3741
ISIN : CA74449F1009
Compare
Compare
Traded in other countries / regions
PBM.USA
IPO Date
2024-01-26
Description
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
Name Current Vs Industry Vs History
Cash-To-Debt 0.07
Equity-to-Asset -9.69
Debt-to-Equity -0.95
Debt-to-EBITDA -0.2
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 10.07
9-Day RSI 17.68
14-Day RSI 22.61
3-1 Month Momentum % -63.97
6-1 Month Momentum % -91.08

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.09
Quick Ratio 0.09
Cash Ratio 0.06

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROA % -4530.02
ROIC % -727.82
ROC (Joel Greenblatt) % -1022120

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -0.22
EV-to-EBITDA -0.22
EV-to-FCF -3.83
Earnings Yield (Greenblatt) % -454.55
FCF Yield % -188.48

Financials

PBM's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PBM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Psyence Biomedical Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -586.5
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility % -
14-Day RSI 22.61
14-Day ATR ($) 0.762229
20-Day SMA ($) 2.99475
12-1 Month Momentum % -
52-Week Range ($) 1.8 - 323.25
Shares Outstanding (Mil) 0.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Psyence Biomedical Ltd Filings

Filing Date Document Date Form
No Filing Data

Psyence Biomedical Ltd Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Psyence Biomedical Ltd Frequently Asked Questions

What is Psyence Biomedical Ltd(PBM)'s stock price today?
The current price of PBM is $1.85. The 52 week high of PBM is $323.25 and 52 week low is $1.80.
When is next earnings date of Psyence Biomedical Ltd(PBM)?
The next earnings date of Psyence Biomedical Ltd(PBM) is .
Does Psyence Biomedical Ltd(PBM) pay dividends? If so, how much?
Psyence Biomedical Ltd(PBM) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1